NOVEOS Specific IgE (sIgE) +5 more— 510(k) K261027

Substantially Equivalent

Hycor Biomedical

FDA 510(k) clearance K261027 for NOVEOS Specific IgE (sIgE) +5 more, Substantially Equivalent on 2026-07-24. Applicant: Hycor Biomedical. Device class: 2.

Summary

Hycor Biomedical's clearance covers NOVEOS Specific IgE (sIgE) and five capture reagents: F014 Soybean, F017 Hazelnut, and three peanut reagents (F352 Ara h 8 PR-10, F423 Ara h 2, and F447 Ara h 6). They're filed under DHB, radioallergosorbent (RAST) immunological test systems.

Class II, 21 CFR 866.5750. Immunology is both the classification panel and the review panel, and it came in as a Traditional 510(k).

Hycor filed from Garden Grove, California. Review took 116 calendar days (March 30 to July 24, 2026).

Clearance details

Device name as filed
NOVEOS Specific IgE (sIgE); Capture Reagent F014, Soybean (Glycine max); Capture Reagent F017, Hazelnut (Corylus avellana); Capture Reagent F352, Ara h 8 PR-10, Peanut; Capture Reagent F423, Ara h 2, Peanut; Capture Reagent F447, Ara h 6, Peanut
Applicant
Hycor Biomedical
Product code
Product code DHB
Device class
Class 2
Regulation
21 CFR 866.5750
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Garden Grove, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code DHB

view all

More clearances from Hycor Biomedical

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.